These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22429463)

  • 1. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
    Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
    Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
    Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
    Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.
    Lisanti MP; Tsirigos A; Pavlides S; Reeves KJ; Peiris-Pagès M; Chadwick AL; Sanchez-Alvarez R; Lamb R; Howell A; Martinez-Outschoorn UE; Sotgia F
    Cell Cycle; 2014; 13(4):580-99. PubMed ID: 24434780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer.
    Sun X; Gierach GL; Sandhu R; Williams T; Midkiff BR; Lissowska J; Wesolowska E; Boyd NF; Johnson NB; Figueroa JD; Sherman ME; Troester MA
    Clin Cancer Res; 2013 Sep; 19(18):4972-4982. PubMed ID: 23918601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer.
    Omar M; Harrell JC; Tamimi R; Marchionni L; Erdogan C; Nakshatri H; Ince TA
    Breast Cancer Res; 2024 Sep; 26(1):132. PubMed ID: 39272208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
    Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
    Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.
    Tan R; Wang L; Song J; Li J; He T
    J Cancer Res Ther; 2017; 13(4):707-714. PubMed ID: 28901319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
    Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
    PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix.
    Wang Y; Lu S; Xiong J; Singh K; Hui Y; Zhao C; Brodsky AS; Yang D; Jolly G; Ouseph M; Schorl C; DeLellis RA; Resnick MB
    J Pathol Clin Res; 2019 Jan; 5(1):40-52. PubMed ID: 30207088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion.
    Shaker H; Bundred NJ; Landberg G; Pritchard SA; Albadry H; Nicholson SL; Harries LJ; Heah JYE; Castle J; Kirwan CC
    Cancer Med; 2020 Mar; 9(5):1768-1778. PubMed ID: 31962001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.
    Wei SC; Fattet L; Tsai JH; Guo Y; Pai VH; Majeski HE; Chen AC; Sah RL; Taylor SS; Engler AJ; Yang J
    Nat Cell Biol; 2015 May; 17(5):678-88. PubMed ID: 25893917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database.
    Hwang KT; Kim EK; Jung SH; Lee ES; Kim SI; Lee S; Park HK; Kim J; Oh S; Kim YA;
    Breast Cancer Res Treat; 2018 Jun; 169(2):311-322. PubMed ID: 29383628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
    Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
    Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
    Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
    Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
    Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
    Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
    Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
    Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of microinvasive breast cancer microenvironment progression.
    Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
    J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.